Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):974-84. doi: 10.1016/j.ijrobp.2007.06.076.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / therapy*
  • Combined Modality Therapy / methods
  • Drug Resistance, Neoplasm / physiology
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / physiology
  • Head and Neck Neoplasms / metabolism
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / physiology
  • Radiation Tolerance / physiology

Substances

  • Antineoplastic Agents
  • Neoplasm Proteins
  • ErbB Receptors